Dark mode is part of the Premium plan.

It is included in the free trial.

Sign inSee Premium
Create a free account
Create a free account

Feeds › Patents

Patents

New US patents granted to public companies.

About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Source and freshness · Information, not investment advice (disclaimer).

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker REGN

Latest patent grants
GrantedPatentOwnerTypeSource
Nov 10, 202612791563
Use of amino acids to enhance signal in mass spectral analyses
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 10, 202612790596
HSD17B13 variants and uses thereof
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 10, 202612788891
Auto-injector with anti-roll features
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 10, 202612788812
Dosing strategy that mitigates cytokine release syndrome for therapeu…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 10, 202612788797
Methods for preventing or treating allergy by administering an IL-4R…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 3, 2026D1156622
Dose delivery device
REGN
Regeneron Pharmaceuticals, Inc.
designGoogle Patents ↗
Nov 3, 202612782326
Methods and systems for assessing chromatographic column integrity
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 3, 202612780928
Compositions and methods for treating juvenile idiopathic arthritis
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 3, 202612780922
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 27, 202612775837
Methods and systems for improved deep-learning models
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 27, 202612774342
Methods of treating multiple myeloma with bispecific anti-BCMA x anti…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 13, 202612760347
Cell culture process for making a glycoprotein
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 13, 202612760122
Mice that make VL binding proteins
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 13, 202612760112
Compositions and methods for enhancing body weight and lean muscle ma…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 13, 202612760099
Multipartite signaling proteins and uses thereof
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 13, 202612758571
Treatment of increased lipid levels with sterol regulatory element bi…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 6, 202612754181
Extraction methods for evaluating suitability of a biochemical filter
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 6, 202612753205
Peptide libraries with non-canonical amino acids
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 6, 202612752006
BCMA chimeric antigen receptors
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 29, 202612747487
Compositions for the treatment of rheumatoid arthritis and methods of…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 29, 202612747300
Methods and antibody compositions for tumor treatment
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 29, 202612747287
Methods of identifying and evaluating cat allergy gene signatures in…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 29, 202612746301
Methods and systems for sterilization
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 29, 202612745761
Non-human animals having humanized Fc-gamma receptors
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 22, 202612742195
Genotyping by sequencing
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 22, 202612741098
Devices and methods for precision dose delivery
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 15, 202612736541
Target-based method for high-throughput and subclass specific IgG gly…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 15, 202612735752
Methods of identifying subjects having an increased risk of developin…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 15, 202612735496
Methods of treating an interleukin-2 receptor gamma-mediated disease…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 15, 202612735469
MAGE-A4 T cell receptors and methods of use thereof
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 15, 202612734300
Devices and methods for precision dose delivery
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 8, 202612730090
pH meter calibration and correction
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 8, 202612729945
Devices and methods for a retainer adapter assembly
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 1, 202612723097
Anti-CD45 antibody drug conjugates and uses thereof
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 1, 202612721914
Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 25, 202612716051
Taurine supplemented cell culture medium and methods of use
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 25, 202612715927
Monospecific antibodies that antagonize leptin receptor
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 25, 202612715921
Anti-PD-1 antibodies for treatment of lung cancer
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 25, 202612715905
Methods of characterizing and purifying VEGF receptor fusion protein
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 18, 202612709642
Methods for treating nasal polyposis by administering an IL-4R antago…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 11, 202612704515
Online native mass spectrometry methods for assaying viral particles
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 11, 202612702709
Methods for treating chronic rhinosinusitis with nasal polyps by admi…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 11, 202612702122
Non-human animals comprising a humanized ACE2 locus
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 4, 202612699101
Maximizing hydrophobic peptide recovery using a mass spectrometry com…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 4, 202612698530
Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhib…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 4, 202612698514
Mammalian cells comprising integrated CAS9 genes to produce stable in…
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 4, 202612696884
Genetically modified non-human animals expressing human EPO
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 28, 202612693277
Systems and methods of pH modeling and control
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 28, 202612693274
Platform for native liquid chromatography-mass spectrometry
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 28, 202612691227
Devices and methods for precision dose delivery
REGN
Regeneron Pharmaceuticals, Inc.
utilityGoogle Patents ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:10 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances